Discover
BNGO
Bionano Genomics, Inc.
1.18
1 x 1.15
1 x 1.19
bid
ask
+
0.00
0.00%
3 @ 04:00 PM
1.19 +0.01 (0.85%)
| Ytd | -22.88% | |
| 1y | -63.24% |
1.13
day range
1.19
1.06
52 week range
4.92
| Open | 1.18 | Prev Close | 1.18 | Low | 1.13 | High | 1.19 | Mkt Cap | 13.54M |
| Vol | 82.16K | Avg Vol | 136.49K | EPS | -4.37 | P/E | -0.27 | Forward P/E | -0.41 |
| Beta | 2.38 | Short Ratio | 3.81 | Inst. Own | 12.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.15 | 200-d Avg | 1.32 | 1yr Est | 1.00 |
| Income Statement | |||
| Total Revenue | 8.17M | ||
| Revenues (USD) | 8.17M | ||
| Cost of Revenue | 3.86M | ||
| Gross Profit | 4.31M | ||
| Operating Expenses | 11.53M | ||
| Research and Development Expense | 2.99M | ||
| Selling, General and Administrative Expense | 8.54M | ||
| Operating Income | -7.22M | ||
| Income Tax Expense | 7.00K | ||
| Net Income | -7.42M | ||
| Net Income Common Stock | -7.42M | ||
| Net Income Common Stock (USD) | -7.42M | ||
| Consolidated Income | -7.42M | ||
| Earnings per Basic Share | -0.64 | ||
| Earnings per Basic Share (USD) | -0.64 | ||
| Earnings per Diluted Share | -0.64 | ||
| Earning Before Interest & Taxes (EBIT) | -7.42M | ||
| Earning Before Interest & Taxes (USD) | -7.42M | ||
| Weighted Average Shares | 11.55M | ||
| Weighted Average Shares Diluted | 11.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.23M | ||
| Cash and Equivalents (USD) | 4.23M | ||
| Investments | 6.19M | ||
| Investments Current | 6.19M | ||
| Trade and Non-Trade Receivables | 4.37M | ||
| Current Assets | 24.88M | ||
| Property, Plant & Equipment Net | 18.95M | ||
| Total Assets | 47.59M | ||
| Debt Current | 876.00K | ||
| Total Debt | 6.70M | ||
| Current Liabilities | 10.04M | ||
| Debt Non-Current | 5.83M | ||
| Total Liabilities | 15.99M | ||
| Accumulated Retained Earnings (Deficit) | -735.35M | ||
| Accumulated Other Comprehensive Income | 14.00K | ||
| Shareholders Equity | 31.61M | ||
| Shareholders Equity (USD) | 31.61M | ||
| Assets Non-Current | 22.71M | ||
| Total Debt (USD) | 6.70M | ||
| Deferred Revenue | 1.26M | ||
| Goodwill and Intangible Assets | 1.67M | ||
| Inventory | 5.20M | ||
| Liabilities Non-Current | 5.95M | ||
| Trade and Non-Trade Payables | 4.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.34M | ||
| Net Cash Flow from Financing | -9.69M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -681.00K | ||
| Issuance (Purchase) of Equity Shares | 594.00K | ||
| Issuance (Repayment) of Debt Securities | -10.29M | ||
| Net Cash Flow from Investing | 13.68M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 13.68M | ||
| Net Cash Flow from Operations | -4.67M | ||
| Effect of Exchange Rate Changes on Cash | 1000 | ||
| Share Based Compensation | 970.00K | ||